Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm receives key regulatory approvals for mps vi study

Jun 18, 2021 at 3:30 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment